APVOVSBIAF• 3 Months (Normalized)
APVO vs BIAF (Aptevo Therapeutics Inc. vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.72
-63.17%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
BIAF Performance $5.35
-57.39%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin BIAF LEADS
-5.78%
BIAF outperforming by 5.78%
APVOBIAF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | APVO Price | APVO Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.72 | -63.17% | $5.35 | -57.39% | -5.78% |
| Sep 15, 2026 | $1.71 | -63.38% | $6.36 | -49.34% | -14.04% |
| Sep 14, 2026 | $1.80 | -61.46% | $7.93 | -36.84% | -24.62% |
| Sep 11, 2026 | $1.82 | -61.03% | $7.95 | -36.68% | -24.35% |
| Sep 10, 2026 | $1.83 | -60.81% | $9.39 | -25.21% | -35.60% |
| Sep 09, 2026 | $1.85 | -60.49% | $10.50 | -16.37% | -44.12% |
| Sep 08, 2026 | $1.88 | -59.74% | $8.93 | -28.87% | -30.87% |
| Sep 04, 2026 | $1.74 | -62.74% | $15.27 | +21.62% | -84.36% |
| Sep 03, 2026 | $1.71 | -63.38% | $12.78 | +1.79% | -65.17% |
| Sep 02, 2026 | $2.60 | -44.33% | $9.75 | -22.34% | -21.99% |
| Sep 01, 2026 | $2.34 | -49.89% | $6.59 | -47.51% | -2.38% |
| Aug 31, 2026 | $2.44 | -47.75% | $4.56 | -63.68% | +15.93% |
| Aug 28, 2026 | $2.37 | -49.36% | $4.87 | -61.21% | +11.85% |
| Aug 27, 2026 | $2.42 | -48.18% | $5.06 | -59.70% | +11.52% |
| Aug 26, 2026 | $2.41 | -48.39% | $5.09 | -59.46% | +11.07% |
Page 1 of 5